Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enact Holdings Inc (ACT) vs UnitedHealth Group Inc (UNH) Price & Performance

Enact Holdings Inc
UnitedHealth Group Inc

Price performance

Price movement over the last 24 hours

Key statistics

Enact Holdings Inc vs UnitedHealth Group Inc — how do they compare? Enact Holdings Inc trades at $45.08 (market cap $6.35B), while UnitedHealth Group Inc trades at $425.11 (market cap $388.86B). The key difference: UnitedHealth Group Inc is far larger — about 61.2× Enact Holdings Inc's market cap, and UnitedHealth Group Inc pays the higher dividend (2.17%). Which is the better fit depends on your goals.

ACTUNH
Market Cap
$6.35B$388.86B
Sector
TechnologyHealth
52-Week High
$45.71$428.19
52-Week Low
$34.39$237.77
Enterprise Value
$6.55B$435.55B
Dividend Yield
1.91%2.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enact Holdings Inc

ACT trades at $45.69, up 0.77% today, with a bullish technical signal and strong moving averages. The stock shows robust fundamentals with a net income margin of 54.49% and a P/E ratio of 9.89. Recent news includes a 14% dividend increase announced on May 5, 2026, and Q1 2026 earnings that met expectations. Analyst consensus is a $47.50 price target with a mix of buy and hold ratings.

Outlook remains positive due to high profitability and dividend growth, but risks include earnings volatility and market sensitivity. Upside is supported by institutional sentiment and consistent cash flow, though investors should monitor execution against future earnings estimates.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $417.99, down 1.73% today, but maintains a bullish technical signal with strong moving averages and support near $414. Revenue grew to $447.57B in 2025, though net income margin compressed to 2.68%. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.

Outlook remains positive with analyst consensus at Buy (82.69%) and a $419.47 price target, though regulatory risks from lawsuits and margin pressures pose challenges. The stock's valuation at a P/E of 31.48 appears rich relative to historical norms, requiring sustained earnings growth to justify further upside.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Enact Holdings Inc

Enact Holdings is a leading private mortgage insurance provider in the U.S. It partners with lenders to offer credit enhancement and risk management solutions, helping more borrowers achieve and maintain homeownership.

Read more on ACT

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH